News

Clinical Trials Arena12h
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...